Related Experiment Video
Updated: Mar 28, 2026
05:06
Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
1.2K
Multidrug efflux pumps in Staphylococcus aureus and their clinical implications
1Institut Pasteur Korea, Seongnam, 13488, Republic of Korea. soojin.jang@ip-korea.org.
Journal of Microbiology (Seoul, Korea)
|January 6, 2016
Summary
Antibiotic resistance is a growing threat, particularly from Staphylococcus aureus. This review summarizes how bacterial multidrug efflux pumps contribute to this resistance and their clinical significance, especially in S. aureus.
Area of Science:
- Microbiology
- Molecular Biology
- Infectious Diseases
Background:
- Antibiotic resistance is a significant global health concern, with bacteria like Staphylococcus aureus posing a major threat.
- Bacterial multidrug efflux pumps are increasingly recognized as key mechanisms contributing to multidrug resistance.
- Understanding these efflux pumps is crucial for developing strategies to combat antibiotic resistance.
Purpose of the Study:
- To provide a concise summary of bacterial multidrug efflux pumps.
- To highlight the clinical implications of efflux-mediated resistance.
- To focus on recent findings related to Staphylococcus aureus efflux pumps.
Main Methods:
- Literature review of studies on bacterial multidrug efflux pumps.
- Analysis of genomic information to identify novel multidrug transporters.
- Synthesis of in vitro and in vivo data on efflux-mediated resistance.
Main Results:
- Multidrug efflux pumps are prevalent in bacteria, including Staphylococcus aureus.
- These pumps actively extrude antibiotics, reducing their intracellular concentration and conferring resistance.
- Efflux-mediated resistance is a significant factor in clinical multidrug resistance observed in S. aureus infections.
Conclusions:
- Bacterial multidrug efflux pumps play a critical role in the spread of antibiotic resistance.
- Targeting these efflux pumps presents a promising strategy to overcome multidrug resistance in Staphylococcus aureus.
- Further research into efflux pump inhibitors is warranted to address the clinical challenge of resistant infections.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
29
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
01:25Mechanism of Antibiotic Resistance in MRSA
78
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
78
01:29Staphylococcal Skin Infections
46
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
46
01:30Development of Antibiotic Resistance
1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
01:27Combined Effects of Drugs: Synergism
7.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.4K
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
114
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
114